Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06738056 · ClinicalTrials.gov registry record
Nerivio Long-term Usage in Patients With Migraine
A clinical trial, sponsored by Theranica.
- Completed
- Registry status
- 244
- Enrollment target
NCT06738056 is a clinical trial that has completed, run by Theranica. The registered enrollment target is 244 participants.
The verdict
NCT06738056 has completed, sponsored by Theranica.
- COMPLETED
- Registry status
- 244 participants
- Enrollment target
Study Summary
This is a post-marketing real-world evidence study investigates long-term treatment with the Remote Electrical Neuromodulation (REN) wearable Nerivio device over 3 consecutive years in patients with migraine.
Interventions
- DEVICE Nerivio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 244 participants |
| Start Date | 2024-12-01 |
| Est. Completion | 2024-12-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06738056
The ClinicalTrials.gov registry entry for NCT06738056 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 244 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Theranica, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nerivio is the first listed.
NCT06738056 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06738056 about?
NCT06738056 is a clinical study titled "Nerivio Long-term Usage in Patients With Migraine". This is a post-marketing real-world evidence study investigates long-term treatment with the Remote Electrical Neuromodulation (REN) wearable Nerivio device over 3 consecutive years in patients with migraine.
What is the current status of trial NCT06738056?
This trial is currently completed. The enrollment target is 244 participants. The study started on 2024-12-01. Estimated completion is 2024-12-22.
What interventions are being tested in trial NCT06738056?
The interventions under investigation include: Nerivio (DEVICE).
Who is sponsoring clinical trial NCT06738056?
This trial is sponsored by Theranica, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.